Detection of clinically relevant T-cell receptors requires tailored approaches, and TCR gene therapy carries inherent risks

Author(s):: Jahn, L.; Heemskerk, M.H.M. (0000-0001-6320-9133)

Published: 2017
Publication type: Article / Letter to editor

Date issued: 2017-08-31
Language: English
Is part of: Translational cancer research (2017), Vol. 6, p. S1118-S1120
hdl: 1887/115751
doi: 10.21037/tcr.2017.07.12